BENITEC BIOPHARMA LIMITED has not announced any capital raises, but we are collecting interest for future raises.
1. Create Account
Complete your onboarding digitally in less than 3 minutes.
2. View Terms
View the full term sheet for the capital raise.
3. Bid for Allocation
Submit and track your bid online.
Benitec Biopharma Limited (BLT) is a biotechnology company focused on the development of treatments for chronic and life-threatening human conditions based on its patented gene-silencing technology, ddRNAi. BLT has also licensed ddRNAi technology and other patent estate to other biopharmaceutical companies. The Company's current focus has been on its hepatitis C therapeutic, TT-034. Former Names Queensland Opals NL (QOP), 30/04/2002; Benitec Limited (BLT), 24/11/2011
1201/99 Mount St, North Sydney NSW 2060, Australia
Fresh Equities does not have BENITEC BIOPHARMA LIMITED directors data.
Fresh Equities does not have BENITEC BIOPHARMA LIMITED announcements data.